Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Husein Husein-ElAhmed & Martin Steinhoff. (2022) Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response. Journal of Dermatological Treatment 33:3, pages 1547-1553.
Read now
Read now
Eric H Kowalski, Diana Kneiber, Manuel Valdebran, Umangi Patel & Kyle T Amber. (2019) Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter]. Clinical, Cosmetic and Investigational Dermatology 12, pages 371-372.
Read now
Read now
Sree S Kolli, Wasim Haidari & Steven R Feldman. (2019) Treatment-resistant prurigo nodularis. Clinical, Cosmetic and Investigational Dermatology 12, pages 345-346.
Read now
Read now
Articles from other publishers (20)
Sarah de Maciel Leite, Leticia Polezuk Scaramussa, Maria Eduarda Fernandes Nunes, Antonio Victor dos Anjos Viana & Leonardo Lora-Barraza. (2023) Uso de talidomida no manejo de prurigo nodular. STUDIES IN HEALTH SCIENCES 4:1, pages 238-243.
Crossref
Crossref
S. Ständer, G. Yosipovitch, J.‐P. Lacour, F.J. Legat, C. Paul, A. Reich, K. Chaouche, F. Ahmad & C. Piketty. (2022) Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances. Journal of the European Academy of Dermatology and Venereology 36:10, pages 1820-1825.
Crossref
Crossref
Danish Javed. (2022) Ayurvedic Management of Prurigo nodularis at scalp: A case report. Journal of Ayurveda and Integrative Medicine 13:4, pages 100668.
Crossref
Crossref
Abdulaziz Albinhamad, Mohammad Almazied, Ru'aa Alharithy & Ahmed Alhumidi. (2022) Acral Prurigo Nodularis: A Case Report. Cureus.
Crossref
Crossref
S. Ständer, C. Zeidler, M. Pereira, J.C. Szepietowski, L. McLeod, S. Qin, N. Williams, T. Sciascia & M. Augustin. (2022) Worst itch numerical rating scale for prurigo nodularis: a psychometric evaluation. Journal of the European Academy of Dermatology and Venereology 36:4, pages 573-581.
Crossref
Crossref
Katherine A. Whang, Thomas K. Le, Raveena Khanna, Kyle A. Williams, Youkyung Sophie Roh, Nishadh Sutaria, Justin Choi, Sylvie Gabriel, Rajeev Chavda, Yevgeniy Semenov & Shawn G. Kwatra. (2022) Health-related quality of life and economic burden of prurigo nodularis. Journal of the American Academy of Dermatology 86:3, pages 573-580.
Crossref
Crossref
L. L. Yang, B. Jiang, S. H. Chen, H. Y. Liu, T. T. Chen, L. H. Huang, M. Yang, J. Ding, J. J. He, J. J. Li & B. Yu. (2021) Abnormal keratin expression pattern in prurigo nodularis epidermis. Skin Health and Disease 2:1.
Crossref
Crossref
Chang Ook Park, Hye Li Kim & Jung-Won Park. (2022) Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development. Yonsei Medical Journal 63:10, pages 881.
Crossref
Crossref
Youkyung S. Roh, Justin Choi, Nishadh Sutaria, Micah Belzberg, Madan M. Kwatra & Shawn G. Kwatra. (2021) IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses. Drugs 81:8, pages 895-905.
Crossref
Crossref
Sarina Elmariah, Brian Kim, Timothy Berger, Sarah Chisolm, Shawn G. Kwatra, Nicholas Mollanazar & Gil Yosipovitch. (2021) Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus. Journal of the American Academy of Dermatology 84:3, pages 747-760.
Crossref
Crossref
Hyun Jeong Byun, Donghwi Jang, Dong-Youn Lee & Jun-Mo Yang. (2021) Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups. Annals of Dermatology 33:4, pages 333.
Crossref
Crossref
Rosemary Oaks, Austin Cusick & Shannon C. Trotter. 2021. Clinical Cases in Pruritus. Clinical Cases in Pruritus
37
41
.
Amy H. Huang, Kyle A. Williams & Shawn G. Kwatra. (2020) Prurigo nodularis. Journal of the American Academy of Dermatology 83:6, pages 1559-1565.
Crossref
Crossref
Katherine A. Whang, Varun Mahadevan, Pegah R. Bakhshi, Kyle A. Williams, Sylvie Gabriel, Rajeev Chavda & Shawn G. Kwatra. (2020) Prevalence of prurigo nodularis in the United States. The Journal of Allergy and Clinical Immunology: In Practice 8:9, pages 3240-3241.
Crossref
Crossref
Mette Deleuran, Victor Georgescu & Catherine Jean-Decoster. (2020) An Emollient Containing Aquaphilus dolomiae Extract is Effective in the Management of Xerosis and Pruritus: An International, Real-World Study. Dermatology and Therapy 10:5, pages 1013-1029.
Crossref
Crossref
Li-Li Yang, Hai-Yan Huang, Zhen-Zhen Chen, Ran Chen, Rong Ye, Wei Zhang & Bo Yu. (2020) Keratin 17 is induced in prurigo nodularis lesions. Open Chemistry 18:1, pages 463-471.
Crossref
Crossref
Nidhi Mahajan, Deeksha Chaturvedi, Anita Alaria & Girendra Pal. (2020) A case report of prurigo nodularis responsive to Homoeopathy. Indian Journal of Research in Homoeopathy 14:1, pages 64.
Crossref
Crossref
Amy H. Huang, Joseph K. Canner, Sewon Kang & Shawn G. Kwatra. (2020) Analysis of real-world treatment patterns in patients with prurigo nodularis. Journal of the American Academy of Dermatology 82:1, pages 34-36.
Crossref
Crossref
Katherine A. Whang, Sewon Kang & Shawn G. Kwatra. (2019) Inpatient Burden of Prurigo Nodularis in the United States. Medicines 6:3, pages 88.
Crossref
Crossref
Sabina-Loredana Corcea, Selda Ali & Roxana Silvia Bumbăcea. (2019) Update on definition and workup of chronic prurigo. Alergologia 3:3, pages 101.
Crossref
Crossref